Now why did I get on this rant
Ozempic (semaglutide) injection is the only GLP-1 RA indicated for adults with T2D and CKD 1 (semaglutide) injection is the only GLP-1 RA indicated for adults with T2D and CKD 1 to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death 1 Actor portrayals
To test this prediction, we have cloned the GST-tagged peptides, and overexpressed them in E
These compounds are not approved by the U.S Food and Drug Administration (FDA) for weight loss, but healthcare providers prescribe these compounds off-label for weight loss and improving metabolic health
Weight Loss: At 36 weeks, weight reductions were dose-dependent: 3.19% (0.5 mg), 7.9210.37% (4 mg), 16.3416.81% (8 mg), and 16.94% (12 mg), compared to 3.0% for placebo and 2.02% for dulaglutide